Original language | English |
---|---|
Pages (from-to) | 3111-3113 |
Number of pages | 3 |
Journal | Journal of Thrombosis and Haemostasis |
Volume | 18 |
Issue number | 11 |
DOIs | |
State | Published - 1 Nov 2020 |
Keywords
- COVID-19
- Vascular Endothelium
- defibrotide
- heparanase
- p38 mitogen-activated protein kinases
- thrombosis
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Thrombosis and Haemostasis, Vol. 18, No. 11, 01.11.2020, p. 3111-3113.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Response to Maccio et al, “Multifactorial pathogenesis of COVID-19-related coagulopathy
T2 - Can defibrotide have a role in the early phases of coagulation disorders?”
AU - Richardson, Edward
AU - Carlo-Stella, Carmelo
AU - Jara, Ruben
AU - Vlodavsky, Israel
AU - Iacobelli, Massimo
AU - Fareed, Jawed
AU - Mo, Clifton
AU - O'Gorman, Peter
AU - Yanik, Gregory
AU - Palomo, Marta
AU - Diaz-Ricart, Maribel
AU - Moraleda, Jose M.
N1 - Funding Information: Edward Richardson has no actual or potential conflict of interest to declare. Dr Carmelo Carlo‐Stella has received research support from ADC Therapeutics and Rhizen Pharmaceuticals; has served as consultant or advisor for Servier, Novartis, Genenta Science srl, ADC Therapeutics, Roche, Sanofi, Karyopharm, and Jazz Pharmaceuticals; and has received honoraria for speaker engagements from Bristol‐Myers Squibb, Merck Sharp & Dohme, Janssen Oncology, and Astra‐Zeneca. Dr Ruben Jara declares honorarium from Edwards Lifesciences and Getinge. Dr Israel Vlodavsky has no actual or potential conflict of interest to declare. Dr Massimo Iacobelli has no actual or potential conflict of interest to declare. Dr Jawed Fareed has no actual or potential conflict of interest to declare. Dr Clifton Mo has no actual or potential conflict of interest to declare. Dr Peter O’Gorman has no actual or potential conflict of interest to declare. Dr Gregory Yanik has grant support from Jazz Pharmaceuticals. Dr Marta Palomo has no actual or potential conflict of interest to declare. Dr Maribel Diaz‐Ricart declares research funding and speaker's fees from Jazz Pharmaceuticals. Dr Jose M. Moraleda reports grants and consulting honoraria from Jazz Pharmaceuticals, during the conduct of the study; consulting honoraria and travel expenses from Gilead, and consulting honoraria from Novartis, Sandoz, and Takeda, outside the submitted work.
PY - 2020/11/1
Y1 - 2020/11/1
KW - COVID-19
KW - Vascular Endothelium
KW - defibrotide
KW - heparanase
KW - p38 mitogen-activated protein kinases
KW - thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85094218713&partnerID=8YFLogxK
U2 - 10.1111/jth.15088
DO - 10.1111/jth.15088
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???
C2 - 32860297
AN - SCOPUS:85094218713
SN - 1538-7933
VL - 18
SP - 3111
EP - 3113
JO - Journal of Thrombosis and Haemostasis
JF - Journal of Thrombosis and Haemostasis
IS - 11
ER -